scholarly article | Q13442814 |
P50 | author | Richard D Hayward | Q42756784 |
Vassilis Koronakis | Q42756793 | ||
P2093 | author name string | Robert J Cain | |
Emma J McGhie | |||
Matthew J Garner | |||
Neil Phillips | |||
P2860 | cites work | CD44 binds to the Shigella IpaB protein and participates in bacterial invasion of epithelial cells | Q24290851 |
Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology | Q24534908 | ||
Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide | Q24546891 | ||
Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease | Q24554202 | ||
Crystal structure determination of cholesterol oxidase from Streptomyces and structural characterization of key active site mutants | Q27617816 | ||
Structure and lipid transport mechanism of a StAR-related domain | Q27622485 | ||
Maintenance of an unfolded polypeptide by a cognate chaperone in bacterial type III secretion | Q27635933 | ||
The 1.45 A resolution structure of the cryptogein-cholesterol complex: a close-up view of a sterol carrier protein (SCP) active site | Q27639545 | ||
Structure of bovine pancreatic cholesterol esterase at 1.6 A: novel structural features involved in lipase activation | Q27749097 | ||
Functional rafts in cell membranes | Q27860768 | ||
Discrete backbone disorder in the nuclear magnetic resonance structure of apo intestinal fatty acid-binding protein: implications for the mechanism of ligand entry | Q28909784 | ||
Port of entry--the type III secretion translocon | Q30320840 | ||
Type III secretion machines: bacterial devices for protein delivery into host cells | Q33639326 | ||
Thiol-activated cytolysins: structure, function and role in pathogenesis | Q33808537 | ||
Assembly and function of type III secretory systems | Q34052773 | ||
Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction | Q34091098 | ||
How cells handle cholesterol. | Q34094514 | ||
Unravelling the significance of cellular fatty acid-binding proteins | Q34251142 | ||
Bacterial invasion: the paradigms of enteroinvasive pathogens | Q34312229 | ||
Rafts can trigger contact-mediated secretion of bacterial effectors via a lipid-based mechanism | Q34347987 | ||
The Yersinia Ysc-Yop 'type III' weaponry | Q34931776 | ||
Microbial pathogenesis and cytoskeletal function. | Q35109715 | ||
Adhesion of enteropathogenic Escherichia coli to host cells. | Q35142691 | ||
Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation | Q35550354 | ||
Homologs of the Shigella IpaB and IpaC invasins are required for Salmonella typhimurium entry into cultured epithelial cells | Q35589961 | ||
Plasma membrane microdomains act as concentration platforms to facilitate intoxication by aerolysin | Q36310741 | ||
Salmonella typhimurium induces membrane ruffling by a growth factor-receptor-independent mechanism | Q36650801 | ||
Cooperation between actin-binding proteins of invasive Salmonella: SipA potentiates SipC nucleation and bundling of actin | Q39644435 | ||
Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas | Q39927824 | ||
The role of cholesterol in the activity of pneumolysin, a bacterial protein toxin. | Q40281548 | ||
Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in gram-positive bacteria | Q40829555 | ||
LcrV is a channel size-determining component of the Yop effector translocon of Yersinia | Q41477086 | ||
Interaction of Ipa proteins of Shigella flexneri with alpha5beta1 integrin promotes entry of the bacteria into mammalian cells | Q41491681 | ||
Direct nucleation and bundling of actin by the SipC protein of invasive Salmonella | Q42680869 | ||
The Salmonella pathogenicity island 1 secretion system directs cellular cholesterol redistribution during mammalian cell entry and intracellular trafficking | Q42817457 | ||
The target cell plasma membrane is a critical interface for Salmonella cell entry effector-host interplay | Q42823992 | ||
Phosphorylation of the enteropathogenic E. coli receptor by the Src-family kinase c-Fyn triggers actin pedestal formation | Q42827785 | ||
The Salmonella-containing vacuole is a major site of intracellular cholesterol accumulation and recruits the GPI-anchored protein CD55. | Q44029864 | ||
Caveolin scaffolding region and cholesterol-rich domains in membranes | Q45168181 | ||
The purified Shigella IpaB and Salmonella SipB translocators share biochemical properties and membrane topology | Q48555964 | ||
Topology of the Salmonella invasion protein SipB in a model bilayer | Q48558570 | ||
Fluorescence of delta 5,7,9(11),22-ergostatetraen-3 beta-ol in micelles, sterol carrier protein complexes, and plasma membranes | Q49248552 | ||
A Salmonella SipB-derived polypeptide blocks the 'trigger' mechanism of bacterial entry into eukaryotic cells | Q50107213 | ||
The Salmonella type III secretion translocon protein SspC is inserted into the epithelial cell plasma membrane upon infection | Q50119640 | ||
Membrane fusion activity of purified SipB, a Salmonella surface protein essential for mammalian cell invasion | Q50119648 | ||
The invasion-associated type III system of Salmonella typhimurium directs the translocation of Sip proteins into the host cell | Q50134497 | ||
Elicitins, Proteinaceous Elicitors of Plant Defense, Are a New Class of Sterol Carrier Proteins | Q57643061 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 590-603 | |
P577 | publication date | 2005-05-01 | |
P1433 | published in | Molecular Microbiology | Q6895967 |
P1476 | title | Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells | |
P478 | volume | 56 |
Q60302097 | A FACS-Based Genome-wide CRISPR Screen Reveals a Requirement for COPI in Chlamydia trachomatis Invasion |
Q36248729 | Acylation of the Type 3 Secretion System Translocon Using a Dedicated Acyl Carrier Protein |
Q40953710 | Amino acid residues within enterohemorrhagic Escherichia coli O157:H7 Tir involved in phosphorylation, alpha-actinin recruitment, and Nck-independent pedestal formation |
Q38695278 | At the crossroads: communication of bacteria-containing vacuoles with host organelles. |
Q34566110 | Bacterial colonization of host cells in the absence of cholesterol. |
Q42799643 | Bile salts stimulate recruitment of IpaB to the Shigella flexneri surface, where it colocalizes with IpaD at the tip of the type III secretion needle |
Q55447105 | CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection. |
Q40601360 | CRISPR/Cas9 Screens Reveal Requirements for Host Cell Sulfation and Fucosylation in Bacterial Type III Secretion System-Mediated Cytotoxicity |
Q26749369 | Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes |
Q37231188 | Characterization of the Binding of Hydroxyindole, Indoleacetic acid, and Morpholinoaniline to the Salmonella Type III Secretion System Proteins SipD and SipB. |
Q40240867 | Cholesterol is required to trigger caspase-1 activation and macrophage apoptosis after phagosomal escape of Shigella |
Q41894482 | Conformational changes in IpaD from Shigella flexneri upon binding bile salts provide insight into the second step of type III secretion. |
Q27671650 | Crystal Structure of PrgI-SipD: Insight into a Secretion Competent State of the Type Three Secretion System Needle Tip and its Interaction with Host Ligands |
Q33326978 | Deciphering interplay between Salmonella invasion effectors |
Q39627554 | Deoxycholate interacts with IpaD of Shigella flexneri in inducing the recruitment of IpaB to the type III secretion apparatus needle tip. |
Q39765360 | Detergent-resistant microdomains mediate activation of host cell signaling in response to attaching-effacing bacteria |
Q40671871 | Divide and conquer: Salmonella move into both daughter cells during mitosis. |
Q30356927 | Effector proteins support the asymmetric apportioning of Salmonella during cytokinesis. |
Q37695614 | Elevated Cholesterol in the Coxiella burnetii Intracellular Niche Is Bacteriolytic |
Q35991625 | Engineered nanoparticles mimicking cell membranes for toxin neutralization |
Q37034994 | Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection |
Q41433037 | Enteropathogenic Escherichia coli, Samonella, Shigella and Yersinia: cellular aspects of host-bacteria interactions in enteric diseases |
Q44349159 | Esterification of cholesterol by a type III secretion effector during intracellular Salmonella infection |
Q37057822 | Exit strategies of intracellular pathogens |
Q46254880 | Haem-iron plays a key role in the regulation of the Ess/type VII secretion system of Staphylococcus aureus RN6390. |
Q37836082 | Hijacking and Use of Host Lipids by Intracellular Pathogens |
Q37727270 | Host-cell lipid rafts: a safe door for micro-organisms? |
Q38694468 | Human genetic variation in VAC14 regulates Salmonella invasion and typhoid fever through modulation of cholesterol. |
Q33884097 | Identification and characterisation of a novel adhesin Ifp in Yersinia pseudotuberculosis |
Q35111099 | Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity |
Q49935385 | Identifying parameters of host cell vulnerability during Salmonella infection by quantitative image analysis and modeling. |
Q34389407 | Influence of oligomerization state on the structural properties of invasion plasmid antigen B from Shigella flexneri in the presence and absence of phospholipid membranes. |
Q31047709 | Injection of Pseudomonas aeruginosa Exo toxins into host cells can be modulated by host factors at the level of translocon assembly and/or activity |
Q46911375 | Insertion of the enteropathogenic Escherichia coli Tir virulence protein into membranes in vitro. |
Q39912831 | Interaction of enteric bacterial pathogens with murine embryonic stem cells |
Q28081987 | Interactions of Salmonella with animals and plants |
Q34796870 | Intestinal Salmonella typhimurium infection leads to miR-29a induced caveolin 2 regulation |
Q37520116 | Leading a sheltered life: intracellular pathogens and maintenance of vacuolar compartments |
Q34975988 | Life on the inside: the intracellular lifestyle of cytosolic bacteria |
Q28253198 | Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome |
Q42128361 | Liposomes recruit IpaC to the Shigella flexneri type III secretion apparatus needle as a final step in secretion induction. |
Q26742013 | Manipulation of host membranes by the bacterial pathogens Listeria, Francisella, Shigella and Yersinia |
Q37823656 | Membrane targeting and pore formation by the type III secretion system translocon |
Q41774328 | Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol |
Q36422508 | Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. |
Q36395663 | Multiplicity of Salmonella entry mechanisms, a new paradigm for Salmonella pathogenesis. |
Q36093299 | Oiling the key hole. |
Q35073836 | OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence |
Q64884800 | Pathways of host cell exit by intracellular pathogens. |
Q42622184 | Pore-forming Activity of the Escherichia coli Type III Secretion System Protein EspD. |
Q37011998 | Preferential invasion of mitotic cells by Salmonella reveals that cell surface cholesterol is maximal during metaphase |
Q30318075 | Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria |
Q34979713 | RNAi screen of Salmonella invasion shows role of COPI in membrane targeting of cholesterol and Cdc42 |
Q41307994 | Role of host cell polarity and leading edge properties in Pseudomonas type III secretion |
Q30577923 | Salmonella enterica invasion of polarized epithelial cells is a highly cooperative effort |
Q34484454 | Salmonella enterica serovar Typhimurium binds to HeLa cells via Fim-mediated reversible adhesion and irreversible type three secretion system 1-mediated docking |
Q37008201 | Salmonellae interplay with host cells |
Q37041854 | Strategies Used by Bacteria to Grow in Macrophages |
Q28732757 | Structural characterization of a novel Chlamydia pneumoniae type III secretion-associated protein, Cpn0803 |
Q37014297 | Structure and biophysics of type III secretion in bacteria |
Q38006509 | Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function |
Q26767237 | The Many Faces of IpaB |
Q35661628 | The N-terminal amphipathic region of the Escherichia coli type III secretion system protein EspD is required for membrane insertion and function |
Q38909275 | The Orchestra and Its Maestro: Shigella's Fine-Tuning of the Inflammasome Platforms. |
Q64256897 | The Virulence Polysaccharide of Typhi Suppresses Activation of Rho Family GTPases to Limit Inflammatory Responses From Epithelial Cells |
Q37075505 | The Yersinia pestis Ail protein mediates binding and Yop delivery to host cells required for plague virulence |
Q42328253 | The bacterial type III secretion system as a target for developing new antibiotics |
Q34005540 | The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection |
Q37968294 | The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen's virulence factors, and the host's mucosal immune response |
Q29617944 | The type III secretion injectisome |
Q33379402 | Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice |
Q39406159 | Type III Secretion in the Melioidosis Pathogen Burkholderia pseudomallei |
Q38019015 | Type III effector-mediated processes in Salmonella infection |
Q39218275 | Type III secretion translocon assemblies that attenuate Yersinia virulence. |
Q28074332 | Type Three Secretion System in Attaching and Effacing Pathogens |
Q37781063 | Uncivil engineers: Chlamydia, Salmonella and Shigella alter cytoskeleton architecture to invade epithelial cells. |
Q38752907 | Use of a Cholesterol Recognition Amino Acid Consensus Peptide To Inhibit Binding of a Bacterial Toxin to Cholesterol |
Q21559505 | Yersinia controls type III effector delivery into host cells by modulating Rho activity |
Search more.